OKUR vs ASMB โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
OKUR Captures Institutional Edge (3โ1 Pillars ยท 5โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to OnKure Therapeutics, Inc. Class A Common Stock (OKUR) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while ASMB counters with relative strength in Valuation. Fundamentally, OKUR trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ASMB at N/M Forward P/E and -31.8% operating margin (-72.6% YoY). In options structure, OKUR sits in SURGE (100th %ile IV; Dealer Gamma Walls on Pro) against ASMB sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | OKUR | ASMB | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $113.7M | $460.7M | Larger Scale | ASMB |
| Trailing P/E Ratio Valuation | N/M | 30.0x | Lower Multiple | ASMB |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | -72.6% | Higher Growth | OKUR |
| Operating Margin (TTM) Profitability | 0.0% | -31.8% | Higher Margin | OKUR |
| Net Profit Margin Profitability | 0.0% | -16.6% | Higher Margin | OKUR |
| Return on Equity (ROE) Capital Efficiency | -55.2% | -4.6% | Higher ROE | ASMB |
| 52-Week Range Position Momentum | 20% ($2โ$5) | 15% ($19โ$40) | Stronger Trend | OKUR |
| Beta / 30D Volatility Risk Regime | 0.96ฮฒ ยท 100% Vol | 0.92ฮฒ ยท 57% Vol | Lower Realized Risk | ASMB |
| Unified Institutional Score Composite Signal | 36.0 / 100 (SELL) | 30.4 / 100 (SELL) | Higher Composite | OKUR |